DURECT Corporation

NasdaqCM:DRRX Rapporto sulle azioni

Cap. di mercato: US$41.6m

DURECT Salute del bilancio

Salute finanziaria criteri di controllo 2/6

DURECT has a total shareholder equity of $5.0M and total debt of $12.5M, which brings its debt-to-equity ratio to 249.1%. Its total assets and total liabilities are $29.9M and $24.8M respectively.

Informazioni chiave

249.1%

Rapporto debito/patrimonio netto

US$12.55m

Debito

Indice di copertura degli interessin/a
ContantiUS$15.65m
Patrimonio nettoUS$5.04m
Totale passivitàUS$24.82m
Totale attivitàUS$29.85m

Aggiornamenti recenti sulla salute finanziaria

Is DURECT (NASDAQ:DRRX) A Risky Investment?

May 12
Is DURECT (NASDAQ:DRRX) A Risky Investment?

Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Jan 08
Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Aug 05
Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Recent updates

Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts

Aug 08
Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts

Durect names ex-RBC Capital Markets executive as CFO

Jul 05

Is DURECT (NASDAQ:DRRX) A Risky Investment?

May 12
Is DURECT (NASDAQ:DRRX) A Risky Investment?

DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be

Mar 14
DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be

DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 10
DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Jan 08
Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?

Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Aug 05
Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?

Durect (DRRX) Investor Presentation - Slideshow

May 06

Durect EPS misses by $0.01, misses on revenue

May 04

DURECT prices ~$43M stock offering

Feb 04

DURECT surges after FDA approval for Posimir

Feb 02

Durect's DUR-928 fast track'd for alcoholic hepatitis in the U.S.

Dec 16

DURECT (DRRX) Investor Presentation - Slideshow

Oct 31

Analisi della posizione finanziaria

Passività a breve termine: DRRX's short term assets ($20.0M) do not cover its short term liabilities ($21.9M).

Passività a lungo termine: DRRX's short term assets ($20.0M) exceed its long term liabilities ($2.9M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: DRRX has more cash than its total debt.

Riduzione del debito: DRRX's debt to equity ratio has increased from 90.9% to 249.1% over the past 5 years.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: DRRX has less than a year of cash runway based on its current free cash flow.

Previsione Cash Runway: DRRX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.6% each year


Scoprire le aziende sane